ACT CAPITAL MANAGEMENT, LLC KRYS Holdings History
ACT CAPITAL MANAGEMENT, LLC's Krystal Biotech Inc Holding Summary
As of 2022-09-30, ACT CAPITAL MANAGEMENT, LLC held 58,300.00 shares of Krystal Biotech Inc(KRYS), totaling $4.06 Mil. This investment constitutes 5.61% of their stock portfolio, and ACT CAPITAL MANAGEMENT, LLC now holds 0.23% of the outstanding Krystal Biotech Inc(KRYS) stock.
The initial trade took place in 2021Q2. And since then ACT CAPITAL MANAGEMENT, LLC has made 2 purchases of KRYS, at an average price of $62.42, for a total of 59,000.00 shares. In addition, there have been 1 sales at an average price of $72.25 for 700.00 shares. Based on historical transaction data and KRYS's current price of $147.49, ACT CAPITAL MANAGEMENT, LLC's estimated gain on his KRYS holdings is $4.97 Mil, reflecting a 134.86% gain to date.
ACT CAPITAL MANAGEMENT, LLC KRYS ($147.49) Holding Chart
ACT CAPITAL MANAGEMENT, LLC KRYS ($147.49) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
